Page last updated: 2024-11-12

syringomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

syringomycin: from Pseudomonas syringae; phytotoxin; small peptide containing molecule [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

syringomycin : A class of cyclodepsipeptides which are secreted by the plant pathogen Pseudomonas syringae. Composed from nine nonribosomally synthesised amino acids bonded to a fatty acid hydrocarbon tail. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11966095
MeSH IDM0101833

Synonyms (2)

Synonym
syringomycin
(2s)-2-[(3s,6s,9z,12s,15s,18s,21r,24r,27s)-18,21-bis(2-aminoethyl)-12-benzyl-3-[(1s)-2-chloro-1-hydroxyethyl]-15-[3-(diaminomethylideneamino)propyl]-9-ethylidene-27-[[(3s)-3-hydroxydodecanoyl]amino]-24-(hydroxymethyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa

Research Excerpts

Overview

Syringomycin E (SR-E) is a low molecular weight bacterial lipodepsipeptide with antifungal properties. It is a necrosis-inducing lipopeptide toxin synthesized by Pseudomonas syringae pv.

ExcerptReferenceRelevance
"Syringomycin is a necrosis-inducing lipopeptide toxin synthesized and secreted by the phytopathogen, Pseudomonas syringae pv. "( Role of biosurfactant and ion channel-forming activities of syringomycin in transmembrane ion flux: a model for the mechanism of action in the plant-pathogen interaction.
Gross, DC; Hutchison, ML; Tester, MA,
)
1.82
"Syringomycin E (SR-E) is a low molecular weight bacterial lipodepsipeptide with antifungal properties. "( Suppression of mitogen-induced lymphocyte proliferation by syringomycin-E.
Singh, VK; Takemoto, JY, 1996
)
1.98
"Syringomycin is a lipodepsinonapeptide phytotoxin synthesized by Pseudomonas syringae pv. "( Analysis of the syrP gene, which regulates syringomycin synthesis by Pseudomonas syringae pv. syringae.
Gross, DC; Quigley, NB; Zhang, JH, 1997
)
2

Toxicity

ExcerptReferenceRelevance
" Syringomycin was much more toxic to growing cells than to stationary-phase cells."( Protection by sterols against the cytotoxicity of syringomycin in the yeast Saccharomyces cerevisiae.
Julmanop, C; Miyakawa, T; Takano, Y; Takemoto, JY, 1993
)
1.45
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (12.73)18.7374
1990's25 (45.45)18.2507
2000's15 (27.27)29.6817
2010's7 (12.73)24.3611
2020's1 (1.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.94 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index38.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.51%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other55 (96.49%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]